SCHEMBL25256441

SCHEMBL25256441

CCCCCCCCC(CCCCCCC)C(=O)OCCCCCCBr

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.47
NAAA Q02083 1/20 0.47
ZDHHC7 Q9NXF8 1/20 0.46
CA2 P00918 2/20 0.44
EPHX1 P07099 1/20 0.44
TSHR P16473 2/20 0.43
DGKA P23743 1/20 0.43
MAPT P10636 2/20 0.42
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
HCAR2 Q8TDS4 1/20 0.41
RAD52 P43351 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CA1 P00915 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ESR1 P03372 1/20 0.41
AKR1C4 P17516 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25616073 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL26722814 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL31255952 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL31229160 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL23461737 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL25340391 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL24587470 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL24586841 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL18665187 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1
SCHEMBL28156388 1.00 FAAH (0.47) FAAHNAAAZDHHC7CA2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034080-A1 CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2025-01-30 US disclosed
EP-4458805-A1 CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF Xiamen Sinopeg Biotech Co., Ltd. (CN) 2024-11-06 EP disclosed
WO-2023126006-A1 CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF 厦门赛诺邦格生物科技股份有限公司 2023-07-06 WO disclosed
WO-2023126006-A1 CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF 厦门赛诺邦格生物科技股份有限公司 2023-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034080-A1 CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF PHOSPHO1, LIPA, SLC7A1 FAAH 390/4885NAAA 283/4885ZDHHC7 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.